4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-017308
Chief Business Development Off sold 416 shares at $61.20 ($25,459)
- Chief Business Development Off acquired 416 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2021-02-19 | Option exercise | +416 | $6.27 | $2,608 | 416 | D: show line 1 in the form |
| BENZENO SHARON Chief Business Development Off | 2021-02-19 | Sale | −416 | $61.20 | $25,459 | 0 | D: show line 2 in the form |
| Open-market sales · 416 sh · avg $61.20 · $25,459 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2021-02-19 | Option exercise · Stock Option (Right to Buy) | −416 | 834 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…